Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain.

There was a slight trend for an increase in moderate and severe adverse events with increasing naloxone dose, but the incidence of serious adverse events was low and generally comparable across all active naloxone PR treatment groups.

also in 4,078 other papers